2024-11-17 07:43:35
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
Corporate/ 2023-07-23
China Biologic Special Committee Retains...

BEIJING,Oct. 17,2019-- China Biologic Products Holdings,Inc. (NASDAQ: CBPO,"China Biologic" or the "Company"),a leading ...

Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.
Health/ 2023-07-22
Kangpu Biopharmaceuticals Successfully C...

SHANGHAI,Oct. 11,2019-- Kangpu Biopharmaceuticals announced today that it has successfully completed a first-in-human phase I single ascendi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release